Tauns Laboratories
197A.TTSE STANDARDPharmaceutical
Filed as TAUNS Laboratories,Inc. (2024-09–2026-09)
In English · 4
Thu, Nov 12 · JST1 filing
15:57MATERIALTauns Laboratories · Change in major shareholderMon, Oct 19 · JST1 filing
13:425% STAKETauns Laboratories · CJP III GP Ltd. + 1 joint holder · 42.18% → 39.29%−2.89ppWed, Dec 24 · JST1 filing
16:455% STAKETauns Laboratories · CJP III GP Ltd. + 1 joint holder · 42.18% → 39.44%−2.74ppThu, Sep 25 · JST1 filing
11:075% STAKETauns Laboratories · Masaki Nonaka · 30.33% → 28.74%−1.59ppAll EDINET filings · 36
| Filed | Document | Source |
|---|---|---|
| 2024-09-27 | CEO/CFO certification | S100UG3N |
| 2024-06-27 | Large shareholding report | S100TV7Y |
| 2024-06-24 | Large shareholding report | S100TQGQ |
| 2024-06-12 | Amended securities registrationRelated to S100TGH4 | S100TLOQ |
| 2024-06-04 | Amended securities registrationRelated to S100TGH4 | S100TK2Q |
| 2024-05-17 | Securities registration | S100TGH4 |
EDINET catalog 2017-01-01 → 2026-10-03; earlier dates still being collected.